Newsfiscal.ai
Molecular Partners Selects MP0730 as Lead Radio-DARPin Candidate
· Published
Article summary
Molecular Partners has selected MP0730, a candidate targeting the CD70 antigen, as the third program in its pipeline of targeted alpha radiotherapeutics.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…